Skip to content

Clinical trials

Phase 1/2 Lymphoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 1/2 Country / region: Italy Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20121
20141
20153
20162
20171
20182
20192
20202
20211
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Terminated6
Completed5
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
AstraZeneca1
BeOne Medicines1
Bristol-Myers Squibb1
Curis, Inc.1
Dren Bio1
Hoffmann-La Roche1
IGM Biosciences, Inc.1
Incyte Biosciences International Sàrl1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma21
Lymphoma, Non-Hodgkin7
Recurrence7
Leukemia5
Lymphoma, Mantle-Cell5
Neoplasms5
Immune System Diseases4
Lymphatic Diseases4
Lymphoproliferative Disorders4
Hodgkin Disease3

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.